218 related articles for article (PubMed ID: 715418)
21. [Therapeutic qualities of a lente preparation of swine insulins manufactured by Pharmachem].
Andreev D; Bozadzhieva E; Pampulov L; Penchev I; Uzunova B
Vutr Boles; 1977; 16(6):59-66. PubMed ID: 341532
[TBL] [Abstract][Full Text] [Related]
22. Effect of lente insulin for treatment of diabetes mellitus in 12 cats.
Bertoy EH; Nelson RW; Feldman EC
J Am Vet Med Assoc; 1995 Jun; 206(11):1729-31. PubMed ID: 7782245
[TBL] [Abstract][Full Text] [Related]
23. Intermediate-acting insulin preparations: NPH and lente.
Deckert T
Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
[TBL] [Abstract][Full Text] [Related]
24. Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.
Czyzyk A; Rogala H; Lawecki J
Acta Diabetol Lat; 1989; 26(1):17-26. PubMed ID: 2665407
[TBL] [Abstract][Full Text] [Related]
25. [The place of "monocomponent" insulins in diabetes mellitus therapy].
Teuscher A
Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
[TBL] [Abstract][Full Text] [Related]
26. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
Bruni B; Turco GL
Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
[No Abstract] [Full Text] [Related]
27. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
Göbel P; Kramer W; Heni F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
[No Abstract] [Full Text] [Related]
28. Circulating antibodies in diabetics treated with conventional and purified insulins.
Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
[TBL] [Abstract][Full Text] [Related]
29. [Characterisation of activity of a biphasic monocomponent insulin (author's transl)].
Neubauer M; Althoff PH; Schnabel O; Genrich V; Schöffling K
Dtsch Med Wochenschr; 1979 Mar; 104(11):384-90. PubMed ID: 421667
[TBL] [Abstract][Full Text] [Related]
30. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
[TBL] [Abstract][Full Text] [Related]
31. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
Andreani D; Iavicoli M; Colletti A; Menzinger G
Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
[No Abstract] [Full Text] [Related]
32. [Comparative study of insulins Novo Monotard and Lente MC].
Scheen A; Scheen-Lavigne M; Luyckx A
Rev Med Liege; 1979 Nov; 34(22):923-7. PubMed ID: 398067
[No Abstract] [Full Text] [Related]
33. [Insulin Monotard and Insulin Lente. Comparison of absorption and clinical effects].
Faber OK; Lauritzen T; Binder C; Mouridsen HT; Volund A
Ugeskr Laeger; 1975 Oct; 137(43):2510-4. PubMed ID: 1103401
[No Abstract] [Full Text] [Related]
34. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
Little JA; Lee R; Sebriakova M; Csima A
Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
[No Abstract] [Full Text] [Related]
35. Letter: Antigenicity of "monocomponent" insulins.
Yue DK; Turtle JR
Lancet; 1974 Oct; 2(7887):1022. PubMed ID: 4138266
[No Abstract] [Full Text] [Related]
36. [The preparation of highly purified insulin and its clinical use. Insulin Cooperative Study Group].
Yang J; Fang F; Zhu X; Deng S; Zhou W; Xing Z
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):178-80. PubMed ID: 1786955
[TBL] [Abstract][Full Text] [Related]
37. [New insulins in diabetes therapy].
Morell B
Schweiz Med Wochenschr; 1979 Mar; 109(10):362-5. PubMed ID: 570723
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of the mono-peak porcine and bovine insulin preparations, Maxirapid and Lente].
Sroczyński J; Pietraszek F; Bresler M; Kuleszyńska G
Pol Tyg Lek; 1986 Mar; 41(11):339-42. PubMed ID: 3520515
[No Abstract] [Full Text] [Related]
39. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.
Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C
Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720
[No Abstract] [Full Text] [Related]
40. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
Martin GJ; Rand JS
J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
